Skip to main contentSkip to navigation
Sirius Investors

CLTEF Stock: Calliditas Therapeutics Ab Stock Price, Analysis & Insights

Get live CLTEF stock price $0.33, comprehensive Calliditas Therapeutics Ab stock analysis, charts, news, and expert forecast. Real-time CLTEF stock data and investment insights.

0.33
52.81%Today
CLTEFCalliditas Therapeutics Ab • Other OTC • Technology
Market Cap
19.80M
Volume
2.00K
52W High
11.46
52W Low
0.00

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Clara Technologies Corp. specializes in delivering IT software solutions tailored for merchants operating on Amazon. Additionally, the firm extends its expertise through professional services, guiding clients in effectively selling their merchandise ...

Company Information

CEO
Jonah Hicks
Sector
Technology
Industry
Software - Application
Employees
N/A

Contact Information

Address
1575 Post Road
Country
SE

Investment Analysis & Business Insights

Technology
Software - Application

Investment Highlights

Strong presence in the Technology sector with established market position

Lower volatility stock (Beta: -1.41) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Calliditas Therapeutics Ab shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Technology may affect company performance
  • Past performance does not guarantee future results for Calliditas Therapeutics Ab
  • Investors should consider how Calliditas Therapeutics Ab fits within their overall portfolio allocation

Market Cap

19.80M

Beta

-1.41

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Technology Sector

The Technology sector includes companies that develop and provide technology products and services, including software, hardware, and digital solutions.